Reply to the letter by Dr. Ulas to themanuscript entitled: "Silybum marianum provides cardioprotection and limits adverse remodeling post-myocardial infarction by mitigating oxidative stress and reactive fibrosis"
Por:
Vilahur, G, Casani, L, Pena, E, Crespo, J, Juan-Babot, O, Ben-Aicha, S, Mendieta, G, Bejar, MT, Borrell-Pages, M, Badimon, L
Publicada:
1 nov 2018
Resumen:
Filiaciones:
Vilahur, G:
IR IIB HSCiSP, Program ICCC, Barcelona, Spain
Inst Salud Carlos III, CIBERCV, Madrid, Spain
Casani, L:
IR IIB HSCiSP, Program ICCC, Barcelona, Spain
Inst Salud Carlos III, CIBERCV, Madrid, Spain
Pena, E:
IR IIB HSCiSP, Program ICCC, Barcelona, Spain
Inst Salud Carlos III, CIBERCV, Madrid, Spain
Crespo, J:
IR IIB HSCiSP, Program ICCC, Barcelona, Spain
Juan-Babot, O:
IR IIB HSCiSP, Program ICCC, Barcelona, Spain
Ben-Aicha, S:
IR IIB HSCiSP, Program ICCC, Barcelona, Spain
Mendieta, G:
IR IIB HSCiSP, Program ICCC, Barcelona, Spain
Bejar, MT:
IR IIB HSCiSP, Program ICCC, Barcelona, Spain
Borrell-Pages, M:
IR IIB HSCiSP, Program ICCC, Barcelona, Spain
Inst Salud Carlos III, CIBERCV, Madrid, Spain
Badimon, L:
IR IIB HSCiSP, Program ICCC, Barcelona, Spain
Inst Salud Carlos III, CIBERCV, Madrid, Spain
Autonomous Univ Barcelona, Cardiovasc Res Chair UAB, Barcelona, Spain
|